Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples